In silico modeling of protein tyrosine phosphatase 1B inhibitors with cellular activity

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 24, 2006, Pages 6321-6327

  Hu, Xin ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Cellular activity; Permeability; PTP1B inhibitors; VolSurf

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR;

ARTICLE; CELL ACTIVITY; CELL MEMBRANE PERMEABILITY; COMPUTER MODEL; DRUG ACTIVITY; PREDICTION; PRINCIPAL COMPONENT ANALYSIS;

ENZYME INHIBITORS; HYPOGLYCEMIC AGENTS; KINETICS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN-TYROSINE-PHOSPHATASE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33750711367     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.09.010     Document Type: Article

References (21)

1. Fischer E.H., Charbonneau H., and Tonks N.K. Science 253 (1991) 401
2. Neel B.G., and Tonks N.K. Curr. Opin. Cell Biol. 9 (1997) 193
3. Saltiel A.R., and Kahn C.R. Nature 414 (2001) 799
4. Elchebly M., Payette P., Michaliszyn E., Cromlish W., Collins S., Loy A.L., Normandin D., Cheng A., Himms-Hagen J., Chan C.C., Ramachandran C., Gresser M.J., Tremblay M.L., and Kennedy B.P. Science 283 (1999) 1544
5. Klaman L.D., Boss O., Peroni O.D., Kim J.K., Martino J.L., Zabolotny J.M., Moghal N., Lubkin M., Kim Y.B., Sharpe A.H., Stricker-Krongrad A., Shulman G.I., Neel B.G., and Kahn B.B. Mol. Cell. Biol. 20 (2000) 5479
6. Blaskovich M.A., and Kim H.O. Expert Opin. Ther. Patents 12 (2002) 871
7. Zhang Z.Y. Annu. Rev. Pharmacol. Toxicol. 42 (2002) 209
8. Harley E.A., and Levens N. Curr. Opin. Investig. Drugs 4 (2003) 1179
9. Bialy L., and Waldmann H. Angew. Chem., Int. Ed. 44 (2005) 3814
10. Dufresne C., Roy P., Wang Z., Asante-Appiah E., Cromlish W., Boie Y., Forghani F., Desmarais S., Wang Q., Skorey K., Waddleton D., Ramachandran C., Kennedy B.P., Xu L., Gordon R., Chan C.C., and Leblanc Y. Bioorg. Med. Chem. Lett. 14 (2004) 1039
11. Liljebris C., Larsen S.D., Ogg D., Palazuk B.J., and Bleasdale J.E. J. Med. Chem. 45 (2002) 1785
12. Malamas M.S., Sredy J., Gunawan I., Mihan B., Sawicki D.R., Seestaller L., Sullivan D., and Flam B.R. J. Med. Chem. 43 (2000) 995
13. Guertin K.R., Setti L., Qi L., Dunsdon R.M., Dymock B.W., Jones P.S., Overton H., Taylor M., Williams G., Sergi J.A., Wang K., Peng Y., Renzetti M., Boyce R., Falcioni F., Garippa R., and Olivier A.R. Bioorg. Med. Chem. Lett. 13 (2003) 2895
14. Liljebris C., Martinsson J., Tedenborg L., Williams M., Barker E., Duffy J.E., Nygren A., and James S. Bioorg. Med. Chem. 10 (2002) 3197
15. Wiesmann C., Barr K.J., Kung J., Zhu J., Erlanson D.A., Shen W., Fahr B.J., Zhong M., Taylor L., Randal M., McDowell R.S., and Hansen S.K. Nat. Struct. Mol. Biol. 11 (2004) 730
16. Cruciani G., Pastor M., and Guba W. Eur. J. Pharm. Sci. 11 Suppl. 2 (2000) S29
17. Crivori P., Cruciani G., Carrupt P.A., and Testa B. J. Med. Chem. 43 (2000) 2204
18. Doddareddy M.R., Cha J.H., Cho Y.S., Koh H.Y., Yoo K.H., Kim D.J., and Pae A.N. Bioorg. Med. Chem. 13 (2005) 3339
19. Xin Z., Liu G., Abad-Zapatero C., Pei Z., Szczepankiewicz B.G., Li X., Zhang T., Hutchins C.W., Hajduk P.J., Ballaron S.J., Stashko M.A., Lubben T.H., Trevillyan J.M., and Jirousek M.R. Bioorg. Med. Chem. Lett. 13 (2003) 3947
20. Cromish W.A., Payette P., and Kennedy B. Biochem. Pharmacol. 58 (1999) 1539
21. Liu G., Xin Z., Pei Z., Hajduk P.J., Abad-Zapatero C., Hutchins C.W., Zhao H., Lubben T.H., Ballaron S.J., Haasch D.L., Kaszubska W., Rondinone C.M., Trevillyan J.M., and Jirousek M.R. J. Med. Chem. 46 (2003) 4232